Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Francelys V. Fernández-Materán"'
Autor:
Lenin González-Paz, Carla Lossada, Maria Laura Hurtado-León, Francelys V. Fernández-Materán, José Luis Paz, Shayan Parvizi, Rafael Eduardo Cardenas Castillo, Freddy Romero, Ysaias J. Alvarado
Publikováno v:
ACS Omega, Vol 8, Iss 8, Pp 7302-7318 (2023)
Externí odkaz:
https://doaj.org/article/fa9c93c803594113b1894ace9381a39c
Autor:
Lenin A. González-Paz, Carla A. Lossada, Francelys V. Fernández-Materán, J. L. Paz, Joan Vera-Villalobos, Ysaias J. Alvarado
Publikováno v:
Frontiers in Physics, Vol 8 (2020)
SARS-CoV-2 has caused millions of infections and more than 600,000 deaths worldwide. Despite the large number of studies to date, there is no specifically effective treatment available for SARS-CoV-2. However, it has been proposed to target reused dr
Externí odkaz:
https://doaj.org/article/0f79827f5a29475b990de781b093c889
Autor:
Lenin González, Carla Lossada, María Laura Hurtado-León, Francelys V. Fernández-Materán, Edgar Portillo, Joan Vera-Villalobos, Marcos Loroño, J. L. Paz, Laura N. Jeffreys, María Dolores Fernández, Ysaias J. Alvarado
Publikováno v:
SSRN Electronic Journal.
Autor:
Laura Jeffreys, José Luis Paz, Carla A. Lossada, Marcos Loroño, Ysaias J. Alvarado, María Laura Hurtado-León, Francelys V. Fernández-Materán, Joan Vera-Villalobos, Lenin A. González-Paz
Publikováno v:
Biophysical Chemistry
The SARS-CoV-2 pandemic has accelerated the study of existing drugs. The mixture of homologs called ivermectin (avermectin-B1a [HB1a] + avermectin-B1b [HB1b]) has shown antiviral activity against SARS-CoV-2 in vitro. However, there are few reports on
Autor:
María Laura Hurtado-León, Ysaias Alvarado, Francelys V. Fernández-Materán, Joan Vera-Villalobos, Marcos Loroño, José Luis Paz, Carla A. Lossada, Laura Jeffreys, Lenin A. González-Paz
Publikováno v:
Journal of Molecular Liquids
The COVID-19 pandemic has accelerated the study of the potential of multi-target drugs (MTDs). The mixture of homologues called ivermectin (avermectin-B1a + avermectin-B1b) has been shown to be a MTD with potential antiviral activity against SARS-CoV
Autor:
Carla A. Lossada, Joan Vera-Villalobos, José Luis Paz, Ysaias J. Alvarado, Lenin A. González-Paz, Francelys V. Fernández-Materán
Publikováno v:
Frontiers in Physics, Vol 8 (2020)
SARS-CoV-2 has caused millions of infections and more than 600,000 deaths worldwide Despite the large number of studies to date, there is no specifically effective treatment available for SARS-CoV-2 However, it has been proposed to target reused drug